Gene · 3113
Papers2,625
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 2,625
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Machine learning applied in maternal and fetal health: a narrative review focused on pregnancy diseases and complications. | Front Endocrinol (Lausanne) | 2023 | 37274341 | PubTator, text mining | PubMed |
| Group A Streptococcus induces CD1a-autoreactive T cells and promotes psoriatic inflammation. | Sci Immunol | 2023 | 37267382 | PubTator, text mining | PubMed |
| Dysregulated early transcriptional signatures linked to mast cell and interferon responses are implicated in COVID-19 severity. | Front Immunol | 2023 | 37261339 | PubTator, text mining | PubMed |
| An ICD-Associated DAMP Gene signature predicts survival and immunotherapy response of patients with lung adenocarcinoma. | Respir Res | 2023 | 37259066 | PubTator, text mining | PubMed |
| Leukemia relapse via genetic immune escape after allogeneic hematopoietic cell transplantation. | Nat Commun | 2023 | 37258544 | PubTator, text mining | PubMed |
| Establishment of a prognostic model for ovarian cancer based on mitochondrial metabolism-related genes. | Front Oncol | 2023 | 37256178 | PubTator, text mining | PubMed |
| Combined analysis of single-cell and bulk RNA sequencing reveals the expression patterns of circadian rhythm disruption in the immune microenvironment of Alzheimer's disease. | Front Immunol | 2023 | 37251379 | PubTator, text mining | PubMed |
| Prognostic Value and Immunological Role of P4HA3 in Colon Adenocarcinoma. | Int J Gen Med | 2023 | 37251280 | PubTator, text mining | PubMed |
| Identifying C1QB, ITGAM, and ITGB2 as potential diagnostic candidate genes for diabetic nephropathy using bioinformatics analysis. | PeerJ | 2023 | 37250717 | PubTator, text mining | PubMed |
| Gene knockout inference with variational graph autoencoder learning single-cell gene regulatory networks. | Nucleic Acids Res | 2023 | 37246643 | PubTator, text mining | PubMed |
| BASP1 expression is associated with poor prognosis and is correlated with immune infiltration in gastric cancer. | FEBS Open Bio | 2023 | 37243901 | PubTator, text mining | PubMed |
| Computational and Experimental Evaluation of the Immune Response of Neoantigens for Personalized Vaccine Design. | Int J Mol Sci | 2023 | 37240369 | PubTator, text mining | PubMed |
| Deciphering the Genetic Code of Autoimmune Kidney Diseases. | Genes (Basel) | 2023 | 37239388 | PubTator, text mining | PubMed |
| Contributions of bone marrow monocytes/macrophages in myeloproliferative neoplasms with JAK2V617F mutation. | Ann Hematol | 2023 | 37233774 | PubTator, text mining | PubMed |
| Down-regulation of S1PR2 is correlated with poor prognosis and immune infiltrates in cervical squamous cell carcinoma and endocervical adenocarcinoma. | Int J Immunopathol Pharmacol | 2023 | 37232164 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing of peripheral blood reveals immune cell dysfunction in premature ovarian insufficiency. | Front Endocrinol (Lausanne) | 2023 | 37223018 | PubTator, text mining | PubMed |
| Identification of Distinct Genetic Profiles of Palindromic Rheumatism Using Whole-Exome Sequencing. | Arthritis Rheumatol | 2023 | 37219934 | PubTator, text mining | PubMed |
| HLA-DQ antibodies in alloimmunity, what makes them different? | Curr Opin Organ Transplant | 2023 | 37219535 | PubTator, text mining | PubMed |
| A novel immunogenic cell death-related subtype classification and risk signature for predicting prognosis and immunotherapy efficacy in gastric cancer. | Front Immunol | 2023 | 37215130 | PubTator, text mining | PubMed |
| Pancancer Analysis Revealed the Value of RAC2 in Immunotherapy and Cancer Stem Cell. | Stem Cells Int | 2023 | 37214785 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3113/papers?page=20